Large Pharmaceutical
Director, VP
Phase II
Dermatology - Vitiligo
Subscribe to our newsletter to receive the latest case studies.
A top-20 pharma company was preparing for the global launch of an alopecia areata treatment.
Each affiliate team was approaching payer negotiations, provider adoption, reimbursement, and market entry differently.
But without a way to capture and share these experiences, affiliates risked duplicating work, missing opportunities, and slowing patient access.
Leadership needed a market access strategy that would unify insights across affiliates, incorporate real world evidence, and accelerate access globally.
Alkemi partnered with the client’s team to capture local market research insights, transform them into practical case studies, and build a digital Navigator platform that made global best practices accessible in real time.
Alkemi conducted in-depth interviews with 12 affiliate teams to identify payer strategies, adoption challenges, and key lessons learned in local markets.
We transformed affiliate experiences into case studies based on real-world data and best-practice playbooks, giving local teams practical tools to guide payer negotiations, communicate value, and assess market opportunities.
Alkemi developed an integrated digital Navigator, a central hub where affiliates could access case studies, tools, and links supported by training modules. This allowed client teams to engage with evidence, adapt pricing strategy inputs, and respond quickly to changes in local healthcare systems.
"There were no airs and graces… with some agencies you get a really young associate transcribing, then multiple layers of people. With them, it was just two-person project team to get things done."
The Global Access Navigator became a repeatable tool for knowledge-sharing across affiliates.
Teams could access proven payer strategies and adapt them to local market conditions, while leadership gained visibility into real-time market dynamics and decision making. This ensured consistency during global rollout and supported broader patient access schemes.
The Navigator has since become a reusable asset for future product launches across therapy areas, reducing duplication, strengthening evidence generation, and accelerating adoption worldwide.
When affiliates operate in silos, opportunities are lost. Alkemi connects local wins into global strategies to help life sciences companies launch smarter, faster, and with greater confidence.